Unloved mutts from 2023 in need of a good home in 2024
The list of the Dogs of the ASX from 2023 is quite similar to the Dogs from 2022 in that it contains several generally considered high quality and would feature prominently in the portfolios of many growth-style fund managers such as ResMed, Treasury Wine and Ramsay Healthcare. Additionally, some companies have previously been featured on the Dogs of the ASX 100, such as AMP and A2 Milk.
The three key themes common to the companies whose share prices struggled in 2023 are:
1. Falling Commodity Prices: Alumina, Iluka, Incitec Pivot and IGO.
2. High price-to-earnings companies are de-rated based on a stock-specific factor that clouds outlook: ResMed, A2 Milk, and IDP Education.
3. Poorly received corporate activity: Ramsay and Treasury Wine
Congratulation to A2! Won again 3years in row !![]()
Add to My Watchlist
What is My Watchlist?